IMARC Group has recently released a new research study titled “Breast Imaging Market: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2023-2028”, offers a detailed analysis of the global breast imaging market share, drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios. The market size reached US$ 4.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.8 Billion by 2028, exhibiting a growth rate (CAGR) of 8.7% during 2023-2028.

Breast imaging refers to the technique of diagnosing breast cancer through high-resolution images of breast tissues in both males and females. It involves numerous ionizing and non-ionizing technologies to screen, detect, and diagnose the type of cancer, its location, and stage of progression. It also utilizes various imaging procedures, such as screening mammography and breast ultrasound, to check for suspicious tissues and the surrounding auxiliary tissues for the early diagnosis of cancer before the actual symptoms appear.

Breast Imaging Market Trends:

The growing incidences of breast cancer are primarily driving the global breast imaging market. Besides this, the increasing awareness regarding the early detection of breast cancer and related diseases is also contributing to the market growth. The World Health Organization (WHO) has identified breast cancer as one of the most prevalent forms of cancer among women. As a result, governments worldwide are taking initiatives and preventive measures to mitigate the risk factors and enhance cancer screening and diagnosis. For instance, the Government of the United Kingdom has launched the “Be clear on cancer” program, which focuses on the early diagnosis of cancer. This has led to a significant rise in the adoption rate of breast imaging procedures across the globe. Moreover, extensive investments in advanced imaging software and hybrid systems, such as automated whole breast ultrasound systems (AWBU) and MBI/BSGI, are also facilitating market growth.

Request a Free PDF Sample of the Report: https://www.imarcgroup.com/breast-imaging-market/requestsample

Key Market Segmentation:

The report has segmented the global breast imaging market based on technology, end-user and region.

Breakup by Technology:

  • Ionizing Breast Imaging
    • Mammography
    • Positron Emission Tomography-Computed Tomography
    • Molecular Breast Imaging
    • Positron Emission Mammography
    • Cone-Beam Computed Tomography
  • Non-Ionizing Breast Imaging
    • Breast Ultrasound
    • Breast MRI
    • Automated Whole-Breast Ultrasound
    • Breast Thermography
    • Electric Impedance Tomography
    • Optical Imaging

Breakup by End-User:

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Competitive Landscape With Key Players:

The competitive landscape of the global breast imaging market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Allengers Medical Systems Limited
  • Aurora Health Care Inc. (Schoen Clinic)
  • Canon Inc.
  • Carestream Health Inc. (Onex Corporation)
  • Delphinus Medical Technologies
  • Dilon Technologies Inc.
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hologic Inc.
  • Koninklijke Philips N.V.
  • Micrima Limited
  • Planmed Oy
  • Siemens Healthineers AG (Cerner Corporation)
  • Toshiba Corporation

Key Highlights of the Report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800